Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021

SELL
$1.69 - $2.85 $8 - $14
-5 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$1.5 - $2.02 $105 - $141
-70 Reduced 93.33%
5 $0
Q3 2020

Nov 12, 2020

SELL
$1.58 - $2.37 $1,657 - $2,486
-1,049 Reduced 93.33%
75 $0
Q2 2020

Aug 14, 2020

BUY
$1.16 - $2.61 $46 - $104
40 Added 3.69%
1,124 $2,000
Q1 2020

May 18, 2020

BUY
$1.06 - $2.16 $1,149 - $2,341
1,084 New
1,084 $2,000

About Akari Therapeutics Plc


  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $165M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.